Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Literature
1.
Leopold C, Wagner AK, Zhang F, Lu CY, Earle C, Nekhlyudov L et al (2016) Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer. Breast Cancer Res Treat 158:333–340CrossRefPubMed
2.
Grant WB, Peiris AN (2012) Differences in vitamin D status may account for unexplained disparities in cancer survival rates between African and White Americans. Dermatoendocrinology 4:85–94CrossRef
3.
Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB et al (2013) Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality—a review of recent evidence. Autoimmun Rev 12:976–989CrossRef
Metadata
Title
Lower vitamin D status may explain racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer
Author
William B. Grant
Publication date
01-08-2016
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2016
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-016-3916-7

Other articles of this Issue 1/2016

Breast Cancer Research and Treatment 1/2016 Go to the issue

Epidemiology

Patterns of change over time and history of the inflammatory potential of diet and risk of breast cancer among postmenopausal women

Review

Therapy modalities to reduce lymphoedema in female breast cancer patients: a systematic review and meta-analysis

Preclinical study

Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein

Clinical trial

Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy

Abstracts

UK Breast Cancer Research Symposium 2016: Submitted Abstracts

Erratum

Erratum to: Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits